Levi S, Bronstein Y, Goldschmidt N, Morabito F, et al. Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study. Am J Hematol 2022 Nov 8. doi: 10.1002/ajh.26779.
PMID: 36349541